Luken Investment Analytics’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4
Closed -$1.31K 178
2025
Q4
$1.31K Buy
+4
New +$1.27K ﹤0.01% 249
2023
Q3
Sell
-63
Closed -$14K 139
2023
Q2
$14K Buy
+63
New +$14.6K 0.01% 112

Other funds holding AMGN

Luken Investment Analytics's AMGN Position: Q1 2026 in Review

Luken Investment Analytics sold out of Amgen (AMGN) in Q1 2026, closing a stake of 4 shares — an estimated $1.31K sold.

Luken Investment Analytics first reported a position in AMGN in Q2 2023 and held it in 2 quarters. The position peaked at $14K in Q2 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Luken Investment Analytics reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Luken Investment Analytics sold 4 Amgen shares in Q1 2026, an estimated $1.31K.
  • Luken Investment Analytics first reported a position in Amgen in Q2 2023 and held it in 2 quarters.
  • Luken Investment Analytics's Amgen position peaked at $14K in Q2 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Luken Investment Analytics's 13F filing for Q1 2026, filed 12 May 2026.